131 results
Page 4 of 7
8-K
EX-99.1
zzyrtcovawtf8dk ae5y
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
04vo4pp
24 Jun 20
Business combination disclosure
4:03pm
425
9uqnj
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.2
wqht6h3b 5vuu
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
n991r9lexvwl
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
wknvh
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
4n7h8v
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
vtvah9koxyadj me
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
S-3ASR
yak5u58gj
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
ncoyeg2e55qwnbq8zi4
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-99.2
rmkfd8z9k5cngl7h1k
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-99.1
d7bg ncjq2gz0
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
nuo0i
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
1bnpjtl7puwnvqxm9
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-99.1
hjgad4gr4ql50ddh60mk
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
S-3ASR
xretbn5pt zpc97hox
18 Mar 20
Automatic shelf registration
10:00pm